Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TEX19 - c-MYC depletion effect on carcinoma cell lines
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TEX19 - Pristimerin effect on myeloma cell lines
TEX19 - Hodgkin and non-Hodgkin lymphoma cell lines
TEX19 - Prostate adenocarcinoma response to radiation (HG-U95D)
TEX19 - 3-Deazaneplanocin A effect on multiple myeloma cells
TEX19 - Autophagy effect on the MHC class II antigenic peptide repertoire
TEX19 - Mutant HLA-F-adjacent transcript 10 overexpression effect on HCT116 colon cancer cell line
TEX19 - Inhibition of Notch signaling in T cell acute lymphoblastic leukemia cell lines
TEX19 - Autism, fragile X syndrome, and 15q11-q13 duplication: lymphoblastoid cells
TEX19 - AIDS-related lymphomas
TEX19 - Kaposi's sarcoma associated herpesvirus protein K13 effect on primary effusion lymphoma-derived BCBL1 cells
TEX19 - Neuroblastoma SKNAS induced cancer stem cells
TEX19 - Oral histone deacetylase inhibitor ST7612AA1 effect on diffuse large B-cell lymphoma in vitro models
TEX19 - BRCA1 depletion effect on HeLa cells
TEX19 - Proteasome inhibitor Bortezomib effect on MCF7 breast cancer cells
TEX19 - Optineurin depletion
TEX19 - Cystic fibrosis pathology and 4-phenylbutyrate (HG-U133B)
TEX19 - Bladder cancer extracellular vesicles
TEX19 - Suberoylanilide hydroxamic acid effect on SKOV-3 ovarian cancer cell line: time course
TEX19 - Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on